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Bacterial vaginosis (BV) is a highly prevalent condition in women. It is associated with poor 
reproductive and health outcomes, including preterm birth and the acquisition of sexually transmitted 
diseases such as HIV infection. The current methods for diagnosing BV may not correctly define the 
vaginal microbiota because identification of bacterial species are typically made using cultivation 
techniques and not all bacteria present can be cultivated. This misidentification can result in an 
inadequate diagnosis of a patient's vaginal health and less than optimal recommendations for 
treatment. In a recent study published in PLOS One, researchers from the laboratory of Dr. David 
Fredricks (Vaccine and Infectious Disease Division) utilized cultivation-independent molecular 
methods to obtain a highly precise characterization of the vaginal microbiota in study subjects. 
Surprisingly, the researchers found that the predominant bacterial species that is typically detected 
in some patients with BV via traditional methods is actually an altogether different species that has 
been misidentified. 
As the most common cause of vaginal discharge, BV is thought to be the result of a shift in the 
vaginal bacterial community. Healthy women without BV show the predominant presence of 
lactobacilli, bacteria believed to promote a healthy ecosystem. When lactobacilli are replaced with 
other bacteria species, such as Gram-negative rods, this can lead to poorer health, the diagnosis of 
BV, and symptoms such as discharge and irritation. However, many women with BV report no 
symptoms. 
"The gold standard method for diagnosing BV relies on detection of particular bacterial shapes and 
their abundances on microscopic examination of vaginal fluid smears," explains lead author and staff 
scientist, Dr. Sujatha Srinivasan. "One indicator of BV is the presence of curved Gram-negative rods 
that were previously thought to represent Mobiluncus species." She and her collaborators sought to 
characterize the vaginal microbiota by detecting bacterial nucleic acids, which would allow for better 
identification of bacterial species through detection of genetic sequences as well as a more precise 
quantification of each species through quantitative polymerase chain reaction (qPCR). They  
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compared their genetic-based results with the bacterial morphotypes as determined by the traditional 
Gram staining of vaginal fluid smears. 
Strikingly, samples containing curved rods that were previously identified as Mobiluncus through 
Gram staining were shown by molecular methods to be a different bacterium named BV-associated 
bacterium 1 (BVAB1). In fact, BVAB1 DNA was 100-fold more abundant than Mobiluncus DNA 
(p<0.001) in BV patient samples. This analysis was further corroborated by fluorescence in situ 
hybridization (FISH) of vaginal fluid smears (see figure). 
According to Drs. Srinivasan and Fredricks, "this study raises the question of whether women who 
have BVAB1-dominant vaginal bacterial communities have distinct risks for the adverse health 
outcomes associated with BV." Additionally, the molecular detection techniques utilized "highlight the 
limitations of using microscopy with Gram stain as a proxy to infer the composition of complex 
microbial communities, and illuminates the increased taxonomic resolution obtained from use of 
molecular tools." 
Indeed, the ability to further improve diagnostic methods will ultimately improve health outcomes. 
The researchers are optimistic that "a better understanding of the precise composition of the vaginal 
microbiota in women will allow researchers to better assess how particular microbes affect disease 
risk, and will pave the way to manipulate the microbiota to optimize health and reproductive 
outcomes."  
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Image provided by Dr. Sujatha Srinivasan. 
Figure Legend: BVAB1, a recently discovered novel bacterium, is the dominant member of vaginal 
bacterial communities in some women with BV. Above: Rank abundance plot showing percentages 
of sequence reads obtained using broad-range PCR with high-throughput sequencing in women with 
curved Gram-negative rods in Gram stains of vaginal fluid. BVAB1 is the most abundant member of 
the vaginal bacterial community in these women. Below: Vaginal fluid smears from a representative 
participant shows that both BVAB1 (green) and Mobiluncus (red) are curved rods. Hence, these 
bacteria cannot be distinguished in Gram stains. 
 
